Clinical Trial Update: The Efficacy of Permethrin 5%, Fusidic Acid 1% and Synthomycine 5% for Demodex - Blepharitis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating a combination of Permethrin 5%, Fusidic Acid 1%, and Synthomycine 5% for Demodex-related blepharitis (inflammation of t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blepharitis
• Inflammation of the Eyelids

Drugs mentioned

• Fusidic Acid 1% (fusidic acid)
• Permethrin 5% (permethrin)
• Synthomycine 5% (tetracycline (synthomycine))

Snippet

Sponsor: Barzilai Medical Center | Conditions: Inflammation of the Eyelids | Phase 4 | Status: UNKNOWN